Abstract
Melanocytes are distinctive cells in the basal layer of the epidermis, the choroid of the eye, certain mucous membranes, and the leptomeninges. Melanocytes arise during embryonal development from pluripotent cells migrating out of the neural crest. Functional maturation, i.e., the process by which cells express specific properties characteristic of the cell type, may progress in melanocytes through several, as yet undefined, stages (Fig. 1). Precursor cells for melanocytes (premelanocytes or melanoblasts) have been identified in human skin1, but these cells have been only preliminarily characterized. The phenotypic and functional characteristics of melanocytes are: a) melanin synthesis through the action of the tyrosinase enzyme; b) dendritic morphology; c) pigment donation to surrounding keratinocytes and d) no detectable proliferation in situ. Despite the undetectable proliferation, a stable 5–6:1 ratio between basal keratinocytes and melanocytes is maintained throughout the life of an individual suggesting a constant renewal of melanocytes.
These studies were supported in part by grants from the NIH, CA-25874, CA-44877, and from the Herzog Foundation.
To whom requests for reprints and all correspondence should be addressed, at The Wistar Institute, 36th Street at Spruce, Philadelphia, PA 19104.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- alpha-MSH:
-
alpha-melanocyte stimulating hormone
- bFGF:
-
basic fibroblast growth factor; BPE, bovine pituitary extract
- CFE:
-
colony forming efficiency
- EGF:
-
epidermal growth factor
- FCS:
-
fetal calf serum
- FSH:
-
follicle stimulating hormone
- IBMX:
-
isobutyl methyl xanthine
- IGF:
-
insulin-like growth factor
- MAb:
-
monoclonal antibody
- MGF:
-
melanocyte growth factor
- MSGA:
-
melanocyte-stimulating growth activity
- NGF:
-
nerve growth factor
- PDGF:
-
platelet derived growth factor
- RGP:
-
radial growth phase
- TPA:
-
12-0-tetradecanoyl phorbol-13-acetate
- VGP:
-
vertical growth phase
References
D. C. Bennet, K. Bridges, and I. A. McKay, Clonal separation of mature melanocytes from premelanocytes in a diploid human cell strain: Spontaneous and induced pigmentation of premelanocytes, J. Cell Sci. 77:167–183 (1985).
D. E. Elder and W. H. Clark, Jr., Developmental biology of malignant melanoma, in: “Pigment Cell”, Vol. 8, R. M. MacKie, ed., Karger, Basel (1987).
W. H. Clark, Jr., D. E. Elder, and M. Van Horn, The biologic forms of malignant melanoma, Hum. Pathol. 17:443–450 (1986).
W. H. Clark, Jr., D. E. Elder, D. Guerry, IV, M. N. Epstein, M. H. Greene, and M. Van Horn, A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma, Hum. Pathol. 15:1147–1165 (1984).
D. E. Elder, D. Guerry, IV, M. N. Epstein, L. Zehngebot, E. Lusk, M. Van Horn, and W. H. Clark, Jr. Invasive malignant melanomas lacking competence for metastasis, Am. J. Dermatopathol. 6:55–62 (1984).
M. Herlyn, M. L. Mancianti, J. Jambrosic, J. B. Bolen, and H. Koprowski, Regulatory factors that determine growth and phenotype of normal human melanocytes, Exp. Cell. Res. 179:322–331 (1988).
M. Herlyn, W. H. Clark, U. Rodeck, M. L. Mancianti, J. Jambrosic, and H. Koprowski, Biology of tumor progression in human melanocytes, Lab. Invest. 56:461–474 (1987).
M. Herlyn, U. Rodeck, M. L. Mancianti, F. M. Cardillo, A. Lang, A. H. Ross, J. Jambrosic, and H. Koprowski, Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture, Cancer Res. 47:3057–3061 (1987).
M. Herlyn, D. Guerry, and H. Koprowski, Recombinant v-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells, J. Immunol. 134:4226–4230 (1985).
J. Thurin, M. Thurin, M. Herlyn, D. E. Elder, Z. Steplewski, W. H. Clark, Jr., and H. Koprowski. GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression. FEBS Lett., 208:17–22 (1986).
M. Herlyn, J. Thurin, G. Balaban, L. J. Bennicelli, D. Herlyn, D. E. Elder, E. Bondi, D. Guerry, P. C. Nowell, W. H. Clark, and H. Koprowski, Characteristics of cultured human melanocytes isolated from different stages of tumor progression, Cancer Res. 45:5670–5676 (1985).
M. L. Mancianti, M. Herlyn, D. Weil, J. Jambrosic, U. Rodeck, D. Becker, L. Diamond, W. H. Clark, and H. Koprowski, Growth and phenotypic characteristics of human nevus cells in culture. J. Invest. Dermatol. 90:134–141 (1988).
G. Balaban, M. Herlyn, D. Guerry, R. Bartolo, H. Koprowski, W. H. Clark, and P. C. Nowell, Cytogenetics of human malignant melanoma and pre-malignant lesions, Cancer Genet. Cytogenet. 11:429–439 (1984).
G. B. Balaban, M. Herlyn, W. H. Clark, Jr., and P. C. Nowell, Karyotypic evolution in human malignant melanoma, Cancer Genet. Cytogenet. 19:113–122 (1986).
M. Herlyn, W. H. Clark, Jr., M. J. Mastrangelo, D. Guerry, IV, D. E. Elder, D. LaRossa, R. Hamilton, E. Bondi, R. Tuthill, Z. Steplewski, and H. Koprowski, Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells, Cancer Res. 40:3602–3609 (1980).
D. Guerry, IV, M. A. Alexander, D. E. Elder, and M. Herlyn, Interferon-Y regulates the T cell response to precursor nevi and biologically early melanoma, J. Immunol., 139:305–312 (1987).
R. Kath, U. Rodeck, J. Jambrosic, and M. Herlyn, Growth factor independence in vitro of primary melanoma cells from advanced but not early or intermediate lesions (Submitted for publication).
U. Rodeck, M. Herlyn, H. D. Menssen, R. W. Furlanetto, and H. Koprowski, Metastatic but not primary melanoma cells grow in vitro independently from exogenous growth factors, Int. J. Cancer 40:687–690 (1987).
B. Westermark, A. Johnsson, Y. Paulsson, C. Betsholtz, C. H. Heldin, M. Herlyn, U. Rodeck, and H. Koprowski, Human melanoma cells lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor, Proc. Natl. Acad. Sci. USA 83:7197–7200 (1986).
J. L. Bennicelli, J. Elias, J. Kern, and D. Guerry, IV, Production of interleukin 1 activity by cultured human melanoma cells, Cancer Res. (in press).
R. Halaban, B. S. Kwon, S. Ghosh, P. S. Delli Bovi, and A. Baird, bFGF as an autocrine growth factor for human melanomas, Oncogene Res. 3:177–186 (1988).
D. Moscatelli, M. Presta, J. Joseph-Silverstein, and D. B. Rifkin, Both normal and tumor cells produce basic fibroblast growth factor, J. Cell. Physiol. 129:273–276 (1986).
A. Richmond, D. H. Lawson, D. W. Nixon, and R. K. Chawla, Characterization of autostimulatory and transforming growth factors from human melanoma cells, Cancer Res. 45:6390–6394 (1985).
M. Eisinger, O. Marko, S.-I. Ogata, and L. J. Old, Growth regulation of human melanocytes: Mitogenic factors in extracts of melanoma, astrocytoma, and fibroblast cell lines, Science 229:984–986 (1985).
A. J. Linnenbach, K. Huebner, E. Premkumar Reddy, M. Herlyn, A. H. Parmiter, P. C. Nowell, and H. Koprowski, Structural alteration in the MYB protooncogene and deletion within the gene encoding α-type protein kinase C in human melanoma cell lines, Proc. Natl. Acad. Sci. USA 85:74–78 (1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Valyi-Nagy, I., Rodeck, U., Kath, R., Mancianti, M.L., Clark, W.H., Herlyn, M. (1991). The Human Melanocyte System as a Model for Studies on Tumor Progression. In: Sudilovsky, O., Pitot, H.C., Liotta, L.A. (eds) Boundaries between Promotion and Progression during Carcinogenesis. Basic Life Sciences, vol 57. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5994-4_26
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5994-4_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5996-8
Online ISBN: 978-1-4684-5994-4
eBook Packages: Springer Book Archive